Celaid Therapeutics
Blood & Organ Banks · Japan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8485,...Phone Number
+81 5036127767Website
www.celaidtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Celaid Therapeutics
Celaid Therapeutics specializes in the research and development of regenerative medical products focused on cell therapy using hematopoietic stem cells, particularly for the treatment of blood cancers such as leukemia. The company aims to develop new cell therapies for blood cancers and genetic disorders by amplifying hematopoietic stem cells sourced from umbilical cord blood and peripheral blood. They utilize advanced technology to create high-quality, cost-effective cell therapy products that can provide new treatment options in the field of hematopoietic stem cell transplantation and gene therapy. Celaid Therapeutics supports global research in regenerative medicine and drug development.Explore more
Celaid Therapeutics Org Chart
TT
Development Office Head
AU
Board Director, CDO, General Manager for BD
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Celaid Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Celaid Therapeutics
Earning: See what the market has to say on Celaid Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Celaid Therapeutics launches new products
Celaid Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Celaid Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Celaid Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Celaid Therapeutics has new funding data
Click to see if Celaid Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Celaid Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Celaid Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Celaid Therapeutics.
Celaid Therapeutics financials insights
Gather financial insights about Celaid Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series B
$7.2M
Celaid Therapeutics Tech Stack
A closer look at the technologies used by Celaid Therapeutics
Most Recent Scoops
Funding
Funding
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
New Hire
Executive Move
Yusuke Inoue has joined the organization as Chief Financial Officer & Chief Operating Officer.
Executive Moves, New Hire
New Hire
Executive Move
Celaid Therapeutics News & Media
Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs
TOKYO, Aug. 28, 2025 /PRNewswire/ -- Celaid Therapeutics Inc. ("Celaid") have executed a collaborative research agreement with AGC Inc. ("AGC") to advance iPS cell-derived hematopoietic stem and progenitor cells (iPSC-HSPCs). The collaboration aims to combine Celaid's proprietary platform...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Celaid Therapeutics
Sign Up For FreeTo access detailed company insights
Celaid Therapeutics specializes in the research and development of regenerative medical products focused on cell therapy using hematopoietic stem cells, particularly for the treatment of blood cancers such as leukemia. The company aims to develop new cell therapies for blood cancers and genetic disorders by amplifying hematopoietic stem cells sourc... Read More
